Guide for patients & caregivers
What Does PI-RADS 3 on a Prostate MRI Mean?
PI-RADS 3 on prostate MRI means an equivocal area. Learn how PSA density and other context shape biopsy or monitoring, and what to ask your specialist.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does PI-RADS 3 mean on a prostate MRI?
PI-RADS 3 means the MRI shows an area whose likelihood of being a clinically significant prostate cancer is intermediate, or undetermined. It is neither reassuring nor clearly suspicious. It is not a cancer diagnosis, and the next step depends on the rest of the clinical picture.
This guide is for adults who have already had a prostate MRI and see PI-RADS 3 in the report. It explains the term and the questions that usually follow. It cannot say whether a particular area is cancer or which next step is right for any one person.
Symptoms that need urgent or earlier care
A PI-RADS score describes a picture; it does not tell anyone to wait if new symptoms appear. Get advice promptly rather than holding on for the next planned appointment if any of the following happens.
- Fever and chills within a few days of a prostate biopsy: RadiologyInfo advises calling the doctor immediately or going to the nearest emergency department, because infection is rare but can be severe.
- Blood in the urine or semen, peeing problems that change, get worse or do not feel normal, or new lower back pain or weight loss without trying: the NHS advises getting these checked by a GP rather than putting them down to the scan result.
- Not hearing about results or next steps: the NHS suggests contacting the hospital or GP if symptoms get worse or there is no update after two weeks.
How does the PI-RADS scale work?
Radiologists use the Prostate Imaging Reporting and Data System (PI-RADS) to report how likely it is that a suspicious area is a clinically significant cancer. The scale has five categories: 1 very low, 2 low, 3 intermediate, 4 high and 5 very high.
"Clinically significant" matters here. Some prostate cancers grow so slowly that they may never cause problems, and the score is aimed at the cancers that are more likely to need attention. The report may list one or more areas (often called lesions) with a score for each, plus a size, the zone of the prostate involved and a prostate volume.
MRI also has limits. RadiologyInfo notes that MRI cannot always tell cancer apart from inflammation or bleeding, which is one reason an area may be called intermediate.
Is PI-RADS 3 cancer?
Not necessarily. A score of 3 sits in the grey zone between areas that are unlikely and likely to be significant cancer. Many PI-RADS 3 areas are not significant cancer, while some are. Biopsy is currently the only way to confirm a prostate cancer diagnosis.
Because of that uncertainty, there is no single rule that every specialist follows. A 2025 open-access study in Frontiers in Oncology notes that consensus on biopsy decisions for scores of 3 and above is still unclear, and that researchers combine the score with other measures to sharpen the decision.
What is PSA density and why does it matter with PI-RADS 3?
PSA density is the PSA blood level divided by the size (volume) of the prostate, usually measured on the MRI. A larger prostate, for example from non-cancerous enlargement, can raise PSA on its own. Adjusting for size helps show how much PSA is being produced for the amount of prostate tissue.
Studies suggest that a higher PSA density alongside a PI-RADS 3 area raises the chance that a biopsy would find significant cancer, while a lower density points the other way. Published studies have used different cut-off values, so there is no universal number to compare against. Ask the specialist what PSA density was calculated, how the prostate volume was measured, and how that figure affects their advice.
If the raised PSA itself is the main question, the separate guide on a first raised PSA result covers what affects PSA and why one reading is not a diagnosis.
Biopsy or monitoring after PI-RADS 3: what is usually discussed?
After an MRI, the NHS says a specialist may suggest a biopsy if they need to find out more. The US National Cancer Institute's clinician summary says that, generally, men with a PI-RADS score of 3 or higher are recommended for an MRI-guided biopsy targeting the suspicious area. In practice, the conversation for a score of 3 is often more individual than for a 4 or 5.
Things a specialist may weigh include the PSA level and PSA density, how PSA has changed over time, the rectal examination, age, general health, family history and personal preferences about the trade-offs of a biopsy. Some people with a lower-risk picture are offered closer follow-up, such as repeat PSA tests or a later MRI, instead of an immediate biopsy. Others are advised to go ahead with a targeted biopsy.
Neither route is a judgement that can be made from the report alone. Ask what the plan is, why that option was chosen for you, and what result or change would alter it.
What happens in a targeted prostate biopsy?
A targeted biopsy uses MRI or ultrasound guidance to take small tissue samples from the area flagged on the scan. It can be done through the rectum or through the skin between the scrotum and anus (the perineum). A pathologist then examines the samples.
RadiologyInfo explains that blood in the urine or stool can occur for a short time afterwards, and that infection is very rare but needs prompt care. The biopsy team will give its own preparation instructions; follow those rather than general advice. Do not stop or change any prescribed medicine, including blood thinners, unless the prescriber or biopsy team tells you to.
Questions to ask the specialist about a PI-RADS 3 result
Bringing the full MRI report and earlier PSA results makes these questions easier to answer. Writing down the replies helps when comparing options later.
- Where is the PI-RADS 3 area, how large is it, and was it the only area scored?
- What is my PSA density, and how was my prostate volume measured?
- How do my PSA history, examination and family history change the picture?
- Do you recommend a targeted biopsy or closer monitoring for me, and why?
- If monitoring, which tests are planned, when, and what would trigger a biopsy?
- If biopsy, which approach would be used, and what are the main risks?
- Who do I contact if symptoms change before the next appointment?
How comparing similar cases on SameCase can help
On SameCase, patients and verified doctors share de-identified cases. Reading how others with a PI-RADS 3 report described their PSA density, the options they were offered and the questions they asked can help you prepare for your own appointment. Other people's cases cannot tell you whether your MRI area is cancer or what your specialist should do; we see them as a way to arrive with clearer questions, not answers.
Sources and further reading
- ACR/RSNA RadiologyInfo: How to read your prostate MRI report and PI-RADS categories (reviewed February 2025)
- ACR/RSNA RadiologyInfo: Prostate MRI and its limits (reviewed June 2026)
- ACR/RSNA RadiologyInfo: Ultrasound- or MRI-guided prostate biopsy (reviewed July 2026)
- National Cancer Institute PDQ (health professional): Prostate cancer screening, MRI and PI-RADS (updated April 2025)
- Li et al., Frontiers in Oncology 2025: PI-RADS v2.1 combined with PSA density for biopsy decisions (CC BY)
- NHS: Tests and next steps for prostate cancer (reviewed July 2025)
- NHS: Symptoms of prostate cancer and when to see a GP (reviewed July 2025)
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.